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Abstract A microcystin (MC)-Sepharose column was prepared by addition of 2-aminoethanethiol to the a&unsaturated carbonyl of the 
N-methyldehydroalanine r sidue of MC-LR, followed by reaction of the introduced amino group with N-hydroxysuccinimide-activated CH- 
Sepharose. The MC-Sepharose bound protein phosphatase-1 (PPl) with high capacity and purified human PPly in one step from E. coli extracts. 
It was also used to purify forms of PPl bound to myofibrils from skeletal muscle. Two of these comprised PPl complexed to N-terminal fragments 
of the M-subunit which enhance its myosin phosphatase activity, while the third comprised PPl and an N-terminal fragment of the glycogen-binding 
(G)-subunit. 
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1. Introduction 
The protein phosphatases (PPs) which dephosphorylate Ser/ 
Thr residues play critical roles in determining the level of phos- 
phorylation and hence the biological activities of many pro- 
teins, which may explain why their structures have been more 
conserved during evolution than any other enzyme. One of the 
two protein (Ser/Thr) phosphatase gene families comprises 
PPI, PP2A, PP2B and many related enzymes [l] which are the 
intracellular targets for a number of drugs, toxins and tumour 
promoters [2]. For example, the calcium/cahnodulin-dependent 
phosphatase (PP2B) is inhibited specifically by the immunosu- 
pressant cyclosporin when the latter is complexed to a protein 
called cyclophilin [3], while the regulatory A-subunit of PP2A 
interacts with the small T-antigen of sarcoma virus 40 and the 
small and medium T-antigens of polyoma virus. Interaction 
with these T-antigens appears to compromise the ability of 
PP2A to inactivate MAP kinase kinase explaining the helper 
function of T-antigens in cell transformation by these viruses 
[4]. PPl, PP2A and other members of this family are also 
inhibited by several naturally occuring toxins, such as okadaic 
acid, the substance responsible for diarrhetic seafood poisoning 
[5], and microcystins, the cyclic heptapeptides produced by 
blue-green algae which are hepatotoxins and a potential threat 
to water supplies [2,6]. Okadaic acid is also a powerful tumour 
promoter [7] and microcystin a potent liver carcinogen [8]. 
Many protein phosphatases do not exist in vivo as the free 
catalytic subunit, but are complexed to other proteins which 
modify their specificities and/or target them to particular 
subcellular locations. For example, ail forms of PP2A are com- 
plexed to the A-subunit, which interacts with many proteins in 
normal cells [9]. One of these, termed the B-subunit, greatly 
increases the activity of PP2A towards some proteins, while 
decreasing its activity towards others [lo]. The catalytic subunit 
of PPl also interacts with many proteins in vivo, which direct 
it to particular subcellular locations and have therefore been 
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termed ‘targetting’ subunits. Targetting subunits may also 
modify the substrate specificity of PPl and/or be subject to 
regulation by phosphorylation or allosteric effecters, allowing 
different forms of PPl to be controlled selectively by extracellu- 
lar signals [l l-131. 
The analysis of protein Ser/Thr phosphatases and their regu- 
latory subunits has been hampered by the difficulty in isolating 
these enzymes. This is due to their low concentrations in cells, 
the complexity of their multiple molecular forms, the suscepti- 
bility of regulatory subunits to proteolysis [14-161 and their 
tendency to dissociate from the catalytic subunit during purifi- 
cation. The development of a simple affinity purification 
method would therefore greatly facilitate the analysis of these 
enzymes. Here we describe an improved microcystin-affinity 
column which has a high capacity for PPl and PPZA, and 
demonstrate its potential for purifying the catalytic subunit of 
PPI and forms of PPl which are complexed to targetting sub- 
units. 
2. Materials and methods 
2.1. Materials 
Microcystin containing leucine and arginine at positions X and Y in 
the ring (MC-LR; Fig. 1) was purified [17] from Microcystis aeruginosa 
harvested from Rutland Water (Leicestershire, UK). MC-YR (contain- 
ing tyrosine and arginine at positions X and Y) was a generous gift from 
Dr. P. Thiel (Research Institute for Nutritional Diseases, Tygerberg, 
South Africa) and Drs. P. Cruz and W. Carmichael (Wright State 
University, Dayton, OH, USA). Both MCs were quantified by amino 
acid analysis [6]. Inhibitor-l [18] and bacterially expressed inhibitor-2 
[19] were purified by Dr. M. Hubbard and Dr. N. Helps, respectively, 
in this laboratory. N-Hydroxysuccinimide-activated CH-Sepharose 4B, 
Mono Q (HR 5/5) and Superose 12 (HR 10/30) columns were from 
Pharmacia G.B. Ltd. (Milton Keynes, UK) and 2-aminoethanethiol 
hydrochloride from Aldrich Chemicals Ltd., Gillingham, UK. 
2.2. Preparation of 32P-labelled substrates and protein phosphatase 
assays 
32P-labelled phosphorylase a (containing 1 .O mol phosphate per mol 
subunit) was prepared by phosphorylation with phosphorylase kinase 
[20] and heavy meromyosin (labelled to 0.8-1.0 mol phosphate per mol 
enzyme (360 kDa)) with skeletal muscle myosin light chain kinase [14]. 
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The dephosphorylation of phosphorylase a (10 PM), and heavy mer- 
omyosin (0.3 PM) were assayed by standard procedures [20]. One 
unit of activity (U) was that amount of enzyme which catalysed the 
release of 1 pm01 of phosphate from each substrate in one min- 
ute. Unless stated otherwise, units refer to activity towards phos- 
phorylase a. 
2.3. Preparation of iodinated microcystin- YR 
MC-YR (1Opg) was dissolved in 0.02 ml of methanol, diluted to 0.1 
ml with 0.125 M sodium phosphate buffer, pH 7.4, and added to a tube 
containing 0.01 mg of dried Iodogen. 
5 ~1 (0.5 mCi) of lz51 sodium iodide was added, and after standing 
for 15 min at O”C, 0.01 ml of 20 mM tyrosine was added followed by 
0.01 ml of 0.5 M (unlabelled) sodium iodide. The solution was diluted 
to 1.0 ml with 0.1% (v/v) tritluoroacetic acid (TFA) and applied to a 
Waters C,s Sep-pak cartridge equilibrated in 0.1% (v/v) TFA. After 
washing with 0.1% (v/v) TFA in 10% (v/v) acetonitrile to remove so- 
dium iodide and tyrosine, the ‘*‘I-MC-YR was eluted with 0.1% TFA/ 
100% (v/v) acetonitrile, dried and redissolved in 0.02 ml of 100% (v/v) 
methanol. 
2.4. Labelring of the PPl catalytic subunit with ‘251-k&elled microcystin 
Fractions containing PPl (20 ~1) were made 0.5% (v/v) in 2-mercap- 
toethanol, incubated for 30 mm at room temperature, diluted to 100~1 
with 50 mM Tris-HCl (PH 7.0), 0.1 mM EGTA, 0.03% (w/v) Brij-35 
and 5 ul ‘Z51-labelled MC-YR (200.000 cmn/ul) was added. After 2 h. 
aliquots were heated for 2 min at 1OO’C in’l% SDS, subjected to 
electrophoresis on SDS/lo% polyacrylamide gels and autoradiogra- 
phed for three days to visualise PPl . 
2.5. Preparation of aminoethanethiol-microcystins 
Water, DMSO and 5 N NaOH were purged separately with N, gas. 
1 vol. MC-LR (l-5 mg/ml in ethanol) was then added to a solution 
comprising 1.5 vol. water, 2 vol. DMSO, 0.67 vol. 5 N NaOH and 1 vol. 
aminoethanethiol hydrochloride (1 g/ml). After incubation for 30 min at 
50°C under N2 gas, the solution was cooled, mixed with an equal 
volume of glacial acetic acid, then diluted 5-fold with 0.1% (v/v) TFA 
and the pH reduced to 1.5 by dropwise addition of 100% (v/v) TFA. The 
sample was applied to a CL8 Seppak cartridge quilibrated in 0.1% (v/v) 
TFA, and after washing with 0.1% (v/v) TFA in 10% (v/v) acetonitrile, 
the aminoethanethiol-MC-LR was eluted from the cartridge with 0.1% 
(v/v) TFA/lOO% (v/v) acetonitrile, dried by rotary evaporation and 
dissolved in 0.02 ml of methanol. Chromatography of an aliquot on a 
Vydac Cls column developed with a gradient of water/acetonitrile in
0.1% TFA showed that 95% of the MC-LR had been converted to the 
aminoethanethiol derivative which was eluted at 33.7% acetonitrile, 
compared with 35.6% acetonitrile for unmodified MC-LR. The ami- 
noethanethiol-derivative of “‘1-MC-YR was prepared in an identical 
manner. 
2.6. Preparation of microcystin-thioethaneamino-Sepharose 
Aminoethanethiol-MC-LR (1 .O mg), spiked with ‘251-aminoethan- 
ethiol-MC-YR (120,000 cpm), was reacted for 34 h at room tempera- 
ture with 6 ml of swollen N-hydroxysuccinimide-activated CH-Sepha- 
rose 4B in 50 mM sodium bicarbonate, pH 9.2. The columns were 
washed alternately with 50 mM Tris-HCl, pH 8,0.5 M NaCl and 50 
mM sodium acetate pH 4,0.5 M NaCl (five times with each buffer) and, 
based on the recovery of ‘251-radioactivity, 97% of the aminoethan- 
ethiol-MC bound covalently to the Sepharose compared to only 3% 
when unmodified MC-YR was used. This con6rmed that the linkage 
to Sepharose was almost entirely through the introduced amino group. 
This MC-thioethaneamino-Sepharose i  referred to hereafter as MC- 
Sepharose. 
2.7. Purzjication of PPI y from Escherichia coli extracts by microcystin 
afinity chromatography 
Escherichia co/i DH5a carrying a pCW-PPly construct was incu- 
bated for 16 h at 28’C with 0.3 mM isopropyl-thio$-Dgalactopyra- 
noside to induce PPl y expression [21]. The cells were then lysed by two 
passes through a French Press in 3 vols of ice-cold 50 mM HEPES- 
NaOH pH 7.5, 100 mM KCl, 5% (v/v) glyeeroc 1 mM EDTA, 2 mM 
MnCl,, 2 mM dithiothreitol, 0.1 mM phenylmethylsulphonyl fluoride 
and 1 mM benzamidine. The homogtnate was centrifuged for 30 mln 
at 14,000 x g and the supematant (termed tht bacterial extract) filttrtd 
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through a 0.45 PM filter. Five ml of the filtrate (containing 50 mg 
protein and 3,000 mU of PPl activity) was loaded on to a 2 ml (0.3 mg 
of ligand) column of MC-Sepharose and the e&mm washed with 100 
ml of 50 mM triethanolamine-HCl, pH 7.5, 0.1 mM EGTA, 5% (v/v) 
glycerol, 0.1% (v/v) 2-mercaptoethanol, 1 mM benzamidine, 1 mM 
uhenvlmethvlsulnhonvl fluoride (Buffer A) containina 0.5 M NaCl and 
i mM MnCl, and B-tier A containing 3 M sod& isothiocyanate 
(NaSCN) and 1 mM MnCl, (5 ml) was passed through the column and 
the flow stopped for 30 min. The flow was restarted and 1 ml fractions 
were collected. The active fractions (6 ml) were pooled, dialysed into 
Buffer A containing 55% (v/v) glycerol plus 1 mM MnCI, and stored 
at -20°C. 
2.8. Purification of forms of PPI from skeletal muscle myojibrils 
The myofibrillar fraction from one New Zealand White rabbit was 
extracted with Triton X-100, and the associated PPl solubilised in 0.6M 
NaCl and fractionated from 3% to 12% poly(ethylene glycol) as de- 
scribed [14]. The 12% poly(ethylene glycol) pellets were resuspended in 
30 ml of 50 mM Tris-HCl, pH 7.0, 0.1 mM EDTA, 0.1 mM EGTA, 
0.6 M NaCl, 0.1% (v/v) 2-mercaptoethanol, 0.03% (w/v) Brij 35, 10% 
glycerol, 1 mM benxamidine, 0.2 mM phenylmethylsulphonyl fluoride, 
0.04 mg/ml leupeptin, 0.1 mg/ml lima bean trypsin inhibitor and 0.5 
mM tosylphenylchloromethyl ketone using a hand homogeniser, incu- 
bated on ice 15 min and centrifuged for 15 min at 180,000 x g. The 
supematant, containing >90% of the activity, was loaded on to a 2.5 
ml column of MC-Sepharose at a flow rate of 1 ml/min. The column 
was washed with 25 mM Tris-HCl, pH 7.0,O.l mM EGTA, 0.03% (w/v) 
Brij 35,0.1% (v/v) 2-mercaptoethanol (Buffer B) containing 0.6 M NaCl 
until the protein concentration in the eluate was < 0.005 mg/ml. Buffer 
B containing 3 M NaSCN (0.75 ml, one void volume) was then passed 
through the column and the flow stopped for 30 min. The flow was then 
restarted and the next 15 ml of Buffer B plus 3 M NaSCN (containing 
the PPl activity) was collected, dialysed against Buffer B and chroma- 
tographed on Mono Q and Superose 12 as described in section 3. 
3. Results 
3.1. Design of the microcystin af$nity column 
The a&unsaturated carbonyl group of the N-methyldehy- 
droalanine (Mdha) residue in MC-LR is arranged with the 
It-electrons polarised so that nucleophilic addition of thiolates 
to the b position is favoured at high pH ([22]; Fig. 1). Reacting 
MC-LR at this position with either ethanethiol or butanethiol 
at pH 11 gave >95% conversion to products which inhibited 
PPl and PP2A with similar potency to the parent toxin (not 
shown), suggesting that thiol addition would provide a suitable 
spacer to immobilise MC for affinity purification of protein 
phosphatases. Immobilisation was achieved by addition of 
Fig. 1. Nucleophilic addition of aminoethanethiol to the p carbon of 
the N-mtthyldthydroalaninc residue of microcystin. In microcystin- 
LR, residue X is leucine and Y is arginine. In microcystin-YR, residue 
X is tyrosint and Y is aqiniae. 
48 G. Moorhead et al. /FEES Letters 356 (1994) 46-50 
2-aminoethanethiol to MC and subsequent reaction of 
aminoethanethiol-MC with N-hydroxysuccinimide-activated- 
Sepharose to form MC-thioethaneamino-Sepharose (MC- 
Sepharose, Fig. 1). 
3.2. Isolation by microcystin af$nity chromatography of human 
PPl y from Escherichia coli extracts 
PPl y was purified to homogeneity from an E. coli extract in 
a single step by MC-Sepharose chromatography (Fig. 2). This 
represented a 130-fold purification from the extract to a final 
specific activity of 38 U/mg, with an apparent recovery of 110%. 
MC-Sepharose chromatography did not change the sensitivity 
of the enzyme to inhibitor-2 (IC, = 2 nM) and microcystin-LR 
(IC,, = 0.4 nM). By titration of MC-Sepharose with purified 
PPl y. the column capacity was found to be 5 mg enzyme/mg 
bound ligand. 
3.3. Isolation by microcystin affinity chromatography of forms 
of PPI bound to skeletal muscle myojibrils 
A substantial proportion of the PPl in skeletal muscle is 
specifically associated with Triton X-lOO-washed myofibrils 
[14]. In the present study we solubilised PPl activity from this 
fraction with 0.6 M NaCl, purified it about 30-fold by fraction- 
ation with poly(ethylene glycol) 8000 as described [14] and a 
further 1,200-fold by chromatography on MC-Sepharose (see 
section 2) The recovery of activity from MC-Sepharose was 
70% and the eluate showed a major 37 kDa band on SDS/ 
PAGE which wmigrated with the catalytic subunit of PPl. 
There were also a number of other bands, most of which were 
identified subsequently as regulatory subunits. 
The MC-Sepharose eluate was chromatographed on Mono 
Q and the fractions assayed for myosin phosphatase as well as 
phosphorylase phosphatase activity. Four peaks of activity 
were resolved, termed PPlC, PPlG’, PPlMa and PPlMg (Fig. 
3). PPlC and PPlG’ had low myosin phosphatase : phosphoryl- 
ase phosphatase activity ratios of ~0.005 and PPlMa and 
1234 
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Fig. 2. Purification of PPl y from Escherichia coli extracts by microcys- 
tin-Sepharose chromatographyLane 1, E. coli extract; Lane 2, the - . 
MC-Skpharose flow-through; Lane 3, MC-Sepharose eluate; Lane 4, 
PPlr mnified bv the procedure of Alessi et al. 1211. Samples were 
denatured in SDS, heated at 100°C for 2 min and sub&ted to electro- 
phoresis on a SDS/12% polyacrylamide gel and stained with Coomassie 
blue. The positions of marker proteins ovalbumin (43 kDa) and car- 
bonic anhydrase (29 kDa) and PPly are indicated. 
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Fig. 3. Separation of myofibrillar forms of PPl by chromatography on 
Mono-Q. The eluate from the MC-Sepharose column was applied to 
a 5 x 0.5 cm column of Mono-Q equilibrated in Buffer B. The column 
was then developed with a 40 ml linear gradient from 0 to 0.4 M NaCl 
in Buffer B at a flow rate of 1.0 ml/min. Fractions of 1.0 ml were 
collected and assayed for myosin phosphatase (a) and phosphorylase 
phosphatase (0) activities. The broken line denotes the NaCl gradient. 
The four peaks termed PPIC, PPlG’, PPlMa and PPlMg were pooled 
as indicated by the solid bars. 
PPlMg high activity ratios of about 0.1. The dephosphoryla- 
tion of phosphorylase or myosin by all four peaks was com- 
pletely inhibited by preincubation for 15 min with 200 nM 
inhibitor-l or inhibitor-5 thermostable proteins which are spe- 
cific PPl inhibitors (data not shown). 
The 37 kDa band in each peak was labelled specifically with 
‘*‘I MC-YR (Fig. 4) demonstrating that this protein was the 
catalytic subunit of PPl. The peak of PPlC (whose amount 
varied from preparation to preparation) eluted from Superose 
12 with an apparent molecular mass of 35 kDa, demonstrating 
that it was the free catalytic subunit. The peak of PPlG’ from 
Mono Q contained a 43 kDa band which stained with similar 
intensity to the 37 kDa catalytic subunit, and a 63 kDa band 
which stained more strongly. The 43 kDa band continued to 
co-purify with the catalytic subunit on Superose 12 (Fig. 5) 
indicating that PPlG’ is a heterodimer. The 63 kDa band eluted 
earlier than PPlG’ (Fig. 5) and is therefore an impurity. Amino 
acid sequencing of several tryptic peptides from the 43 kDa 
subunit showed 100% identity with sequences found in the 
N-terminal domain of the glycogen binding (G)-subunit of PPl 
1231. 
The peak of PPlMu from Mono Q contained a 35 kDa band 
which stained with similar intensity to the 37 kDa catalytic 
subunit, and continued to copurify with it on Superose 12 (Fig. 
5). Similarly, PPlMg was also a heterodimer comprising a 50 
kDa subunit complexed to PPlC (Fig. 5). Tryptic digestion and 
peptide sequencing revealed that several peptides from the 35 
kDa subunit of PPlMa were identical to peptides found in the 
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Fig. 4. Labelling of myofibrillar forms of PPl with ‘%nicrocystin YR. 
PPlC, PPlG’, PPlM& and PPlMJifrom Fig. 3 and PPlM from chicken 
gizzard 1271 were incubated with “‘1-MC-YR. denatured in SDS. 
heated at ?OO’C for 2 min, electrophoresed’ on SDS/IO% poly: 
acrylamide gels and autoradiographed. Lane 1, PPlC; Lane 2, PPlG’, 
Lane 3, PPlMa, Lane 4, PPlM@; Lane 5 PPlM purified from chicken 
gizzard [271. The positions of the PPl catalytic subunit and the marker 
proteins bovine serum albumin (66 kDa), ovalbumin (43 kDa) and 
carbonic anhydrase (29 kDa) are indicated. 
50 kDa subunit of PPlM/T. Coupled with the high myosin 
phosphatase:phosphorylase phosphatase activity ratios of both 
species, this indicates that the 35 kDa and the 50 kDa subunits 
are likely to be derived from the same gene. Several peptides 
from the 35 and 50 kDa subunits also showed considerable 
homology to the ankyrin repeat region of the M,i,, subunit of 
smooth muscle PPlM, located near the N-terminus [24]. These 
results indicate that the N-terminal domain of the M,,,-subunit 
contains the PPl-binding site and the site which enhances the 
dephosphorylation of myosin. 
4. Dlscu&on 
In this paper we imtnobilised MC via a site that is not essen- 
tial for the toxin-enzyme interaction to produce a powerful 
affinity column which is capable of producing l,OOO-fold puri- 
fication of either the catalytic subunit or native complexes of 
PPl in a single step and in quantities sufficient for structural 
analysis. Indeed the capacity of the column (5 mg PPl per mg 
MC) is 15% of the theoretical maximum. The key to the proce- 
dure was the use of a low molecular weight thiol which reacted 
with the Mdha sufficiently rapidly that coupling was complete 
before the MC was degraded under the alkali conditions used. 
The resulting thiol adduct was then resistant o alkali, probably 
because the susceptible peptide bond between the Mdha and 
Glu residues was stabilised once nucleophilic addition to Mdha 
had been achieved. The added thiol also contained an amino 
group which permitted linkage to N-hydroxysuccinimide-acti- 
vated CH-Sepharose. In principle, MC could be linked to other 
matrices using the same chemistry. 
Two other laboratories have previously described the use of 
MC affiity columns. Nishiwaki et al. 1251 coupled MC-LR to 
ECH-Sepharose using carbodiimide and used it to purify 
PP2A, from a mouse brain extract. However, the capacity of 
the column was over lOOO-fold lower than that reported here, 
only 3 pg PP2A being bound per mg MC. Moreover, no PPl 
bound to the column. Beullens et al. [26] coupled MC-LR to 
epoxy-activated Sepharose (M. Bollen, personal communica- 
tion) and used the resulting matrix to purify PPlC to a high 
specific activity. The PPl was eluted from the MC-column with 
3 M KSCN and we therefore adopted a thiocyanate elution 
procedure ourselves. The capacity of their column was not 
reported, but one of us (C.M.) found that columns made by 
linking to epoxy-activated Sepharose bound less than 10 pug 
PPl y/mg of coupled MC. 
The binding of MC to PPl (Fig. 4) or PP2A (data not shown) 
is stable to heating at 100°C in 1% SDS, suggesting that MC 
binds covalently to these phosphatases. Indeed, one of us 
(R.W.M. unpublished work) has isolated a tryptic peptide con- 
PPI G’ 
PPlMd 
F L647L8 49 50 51 
8. 
,. 
43-’ 
/C 
29- 
\Mot 
PPlM@ 
29- 
Fig. 5. Gel filtration of the myofibrillar forms of PPl. PPlG’, PPlMa 
and PPlMg from Mono Q (Fig. 3) were each concentrated to 200 ~1 
by ultrafiltration through Centricon 10 and applied to a 30 x 1 cm 
column of Superose 12 equilibrated in Buffer B containing 0.1 M NaCl. 
The flow rate was 0.5 ml/min and 0.25 ml fractions (F) were collected. 
The marker proteins were eluted from Superose 12 at fraction 41 (bo- 
vine serum albumin diier, 132 kDa), fraction 45 (bovine serum albu- 
min monomer, 66 kDa), fraction 49 (ovalbumin, 43 kDa) and fraction 
54 (carbonic anhydrase, 29 kDa). Aliquots of the phosphorylase phos- 
phatase-containing fractions were electrophoresed on SDS/IO% poly- 
acrylamide gels and stained with Coomassie blue. The positions of the 
catalytic subunit of PPl (C), the glycogen binding subunit (G’) and the 
myosin phosphatase nhancing subunits (Ma, MB) are indicated and 
the marker proteins are as in Fig. 4. 
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taming the MC-binding site. This suggests that either the cova- 
lent linkage is labile in NaSCN, or that the immobilisation of 
MC prevents the covalent interaction with PPl. 
It has been reported previously that the myofibrillar fraction 
of skeletal muscle contains two forms of PPl, one of which 
(PPlM) has a high activity towards myosin, and evidence has 
been provided that the high myosin phosphatase activity of 
PPlM is conferred by another (M)-subunit [14]. In this earlier 
study, a nine step procedure was needed to purify PPlM over 
lOO,OOO-fold from the myofibrillar fraction, but the final prod- 
uct contained a 33 kDa proteolytic fragment of the PPl cata- 
lytic subunit and the putative M-subunit could not be detected 
by SDS/PAGE. The MC-Sepharose affinity column allowed 
skeletal PPlM to be purified within two days and the final 
product contained the undegraded catalytic subunit complexed 
to M-subunits which were structurally related to the function- 
ally distinct Mllo -subunit from smooth muscle [24, 271. It is 
possible that the failure to detect he M-subunit previously [14] 
resulted from co-migration of the 33 kDa fragment of the cat- 
alytic subunit with the 35 kDa fragment of the M-subunit 
(Fig. 5). 
MC-Sepharose affinity chromatography also purified an- 
other myofibrillar form of PPl to near homogeneity which 
contained a 43 kDa subunit bound to PPlC. Tryptic peptides 
from the 43 kDa species were all identical to sequences found 
near the N-terminus of the G-subunit which targets PPI to both 
the glycogen particles and the membranes of the sarcoplasmic 
reticulum (SR). We therefore conclude that the 43 kDa protein 
is a fragment of the 124 kDa G-subunit [11,23]. This fmding was 
somewhat unexpected since the myofibrils had been extracted 
several times with Triton X-100 which solubilises the SR and 
therefore the PPl which is bound to these membranes. The 
results suggest hat the myofibrils bind significant amounts of 
glycogen and its associated enzymes, which are not extracted 
at low ionic strength or with detergent, but released when the 
myofibrils are solubilised in 0.6 M NaCI. 
The MC-Sepharose affinity column we have developed also 
has a high capacity for binding PPZA, but we have been unable 
thus far to recover significant PP2A activity. Nevertheless, the 
column should be useful for the isolation of regulatory subunits 
of PP2A as well as the regulatory and catalytic subunits of other 
microcystin-sensitive protein phosphatases. 
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